Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit

Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.

Lupin receives USFDA approval for generic Ravicti oral liquid

Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders

Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice

Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth

India’s SS Innovations performs 10,000-km robotic telesurgery between Australia and Indore

Dr Mohit Bhandari remotely conducted a complex robotic gastrojejunostomy from Perth using the indigenous SSI Mantra Surgical Robotic System

SetPoint Medical launches first-in-human MS pilot study using implanted nerve stimulation device

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor